Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 382 for human
Company Exchange Symbol Last price Quote change Market cap
Human Genome Sciences NASDAQ HGSI 0.0000 2.85B
Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) ...
PerkinElmer, Inc. NYSE PKI 47.65 0.00 (0.00%) 5.39B
It operates in two segments: Human Health and Environmental Health. The Company's Human Health segment concentrates on developing diagnostics, ...
Grifols SA, Barcelona NASDAQ GRFS 41.53 0.00 (0.00%) 5.43B
BioTime, Inc. NYSEMKT BTX 2.78 0.00 (0.00%) 200.58M
... such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend.
Amgen, Inc. NASDAQ AMGN 121.11 0.00 (0.00%) 91.68B
Amgen Inc. is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics. Its medicines help millions of patients ...
Halozyme Therapeutics, Inc. NASDAQ HALO 9.07 0.00 (0.00%) 1.13B
The Company's research focuses primarily on human enzymes that alter the extracellular matrix. The Company's pipeline consists of multiple clinical stage ...
XOMA Corp NASDAQ XOMA 4.03 0.00 (0.00%) 430.27M
XOMA Corporation (XOMA) is engaged in the discovery and development of antibody- based therapeutics. The Company's lead drug candidate is gevokizumab ...
The Providence Service Corporation NASDAQ PRSC 38.87 0.00 (0.00%) 566.26M
The Providence Service Corporation provides and manages government sponsored social services and non-emergency transportation services.
Human Pheromone Sciences, Inc. OTCMKTS EROX 0.0410 0.0000 (0.00%) 170,230.00
Human Pheromone Sciences, Inc. (HPS) is engaged in the research, development, manufacturing and marketing of consumer products containing synthetic human ...
StemCells Inc NASDAQ STEM 1.74 0.00 (0.00%) 118.18M
The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human ...
PERKINELMER INC. DL 1 FRA PKN 35.04 +0.57 (1.66%)
Rhino Human Resources, Inc. OTCMKTS IFHR 0.0011 0.0000 (0.00%) 31,432.00
Rhino Human Resources Inc, formerly Infe-Human Resources, Inc., through its subsidiary, Daniels Corporate Advisory Company, Inc. (Daniels), is engaged in ...
3SBio Inc. (ADR) NASDAQ SSRX 16.59 366.10M
3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on ...
Victhom Human Bionics Inc. TSE VHB 0.120 0.000 (0.00%) 1.84M
Victhom Human Bionics Inc. (Victhom) is engaged in discovering and developing bionic devices in the field of orthotics and prosthetics.
Celgene Corporation NASDAQ CELG 86.66 0.00 (0.00%) 69.40B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer ...
China Biologic Products Inc NASDAQ CBPO 46.17 0.00 (0.00%) 1.13B
The Company is approved to sell human albumin with dosages of 20%/10 milliliters , 20%/25 milliliters, 20%/50 milliliters, 10%/10 milliliters, ...
Kamada Ltd. TLV KMDA 2,263.00 -27.00 (-1.18%) 813.77M
It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company's product line ...
Biodel Inc NASDAQ BIOD 1.89 0.00 (0.00%) 39.91M
Biodel Inc. (Biodel) is a development-stage specialty biopharmaceutical company focused on the development and commercialization of treatments for diabetes.
Accord Human Resources, Inc. Private
Accord Human Resources, a professional employer organization (PEO), provides outsourced human resource services to some 700 small and midsized business ...
Novo Nordisk A/S (ADR) NYSE NVO 46.02 0.00 (0.00%) 195.64B
It has a range of diabetes product portfolio, including a portfolio of modern insulins and the first human once-daily GLP-1 analog.